Long term immunological effects of S1P modulators in MS patients switching to Ocrelizumab or Natalizumab Anna Rolando,Stella Marasciulo,Chiara Bosa, Paola Garelli,Paola Cavalla,Marco VercellinoMULTIPLE SCLEROSIS JOURNAL(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要